The Generalisability of Pharmacoeconomic Studies James Mason Leading Article 27 November 2012 Pages: 503 - 514
Constraints on Antidepressant Prescribing and Principles of Cost-Effective Antidepressant Use John A. HenryCarol A. Rivas Review Article 27 November 2012 Pages: 515 - 537
Cost Effectiveness of Smoking-Cessation Therapies Kenneth E. Warner Review Article 27 November 2012 Pages: 538 - 549
A Pharmacoeconomic Analysis of Patients with Symptoms of Benign Prostatic Hyperplasia Paul C. CockrumSteven F. FinderRoger P. Potyk Original Research Article 27 November 2012 Pages: 550 - 565
Cost-Benefit Analysis of Prophylactic Granulocyte Colony-Stimulating Factor During CHOP Antineoplastic Therapy for Non-Hodgkin’s Lymphoma George DranitsarisChristopher AltmayerIan Quirt Original Research Article 27 November 2012 Pages: 566 - 577
Some Aspects of the Cost of Schizophrenia in France Frédéric RouillonMondher ToumiPascal Auquier Original Research Article 27 November 2012 Pages: 578 - 594
Erratum to Will Managed Care Work in Europe? E. MossialosP. KanavosB. Abel-Smith Erratum 27 November 2012 Pages: 594 - 594
Incremental Cost-Effectiveness Ratio of Alteplase in Patients with Acute Myocardial Infarction in the French Setting Alain PelcJacques DardenneGuy Hanania Original Research Article 27 November 2012 Pages: 595 - 605
Cost Effectiveness and Allocation of Therapies in a Treating Population Göran KarlssonMagnus Johannesson Correspondence 27 November 2012 Pages: 606 - 606
Cost Effectiveness and Allocation of Therapies in a Treating Population: The Author’s Reply Paul C. Langley Correspondence 27 November 2012 Pages: 606 - 608
Pre-Hospital Thrombolysis: The Author’s Reply Stuart BartonTom Walley Correspondence 27 November 2012 Pages: 608 - 609